More importantly, some miRNAs can induce tumor cell proliferation, thereby reducing the sensitivity of drugs, such as miR-96, which can promote cell proliferation by targeting RECK and lower the chemotherapy sensitivity of esophageal cancer cells(41). Here, RECK is linked to neoplasm.